ITEM 2.02 Results of Operations and Financial Condition.
The following information is furnished pursuant to Item 2.02, "Results of
Operations and Financial Condition." On August 11, 2009, we issued a press
release announcing our operating results for the second quarter ended June 30,
2009. The text of the press release is furnished as Exhibit 99.1 to this Form
8-K.
The information in Item 2.02 of this Form 8-K and the Exhibit 99.1 attached
hereto shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange Act, except as
expressly set forth by specific reference in such filing.
ITEM 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release issued by ImaRx Therapeutics, Inc. on August 11, 2009.